Zobrazeno 1 - 5
of 5
pro vyhledávání: '"T du Repaire"'
Publikováno v:
Section 5: Patient safety and quality assurance.
Publikováno v:
Section 5: Patient safety and quality assurance.
Autor:
F Benjamin, T du Repaire, M Montana, R Fanciullino, N Ausias, B Deluca, L Gauthier Villano, B Pourroy
Publikováno v:
Section 5: Patient safety and quality assurance.
Autor:
P Vigne, Laurence Gauthier-Villano, Bertrand Pourroy, P Bertault-Peres, T du Repaire, A Savry
Publikováno v:
Clinical pharmacy.
Background The Food and Drug Administration has just approved blinatumomab for the treatment of paediatric patients with Philadelphia chromosome negative acute lymphoblastic leukaemia (ALL). 1 Recommended doses in children are 5 μg/m 2 /day for 1 we
Autor:
Du Repaire T; Pharmacy DepartmentLa Timone University Teaching HospitalMarseille, France., Vigne P; Pharmacy DepartmentLa Timone University Teaching HospitalMarseille, France., Guedon A; Pharmacy DepartmentLa Timone University Teaching HospitalMarseille, France., Fanciullino R; Pharmacy DepartmentConception University Teaching HospitalMarseille, France., Gauthier-Villano L; Pharmacy DepartmentLa Timone University Teaching HospitalMarseille, France., Peres PB; Pharmacy DepartmentLa Timone University Teaching HospitalMarseille, France., Pourroy B; Pharmacy DepartmentLa Timone University Teaching HospitalMarseille, Francebertrand.pourroy@ap-hm.fr.
Publikováno v:
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists [Am J Health Syst Pharm] 2017 Aug 15; Vol. 74 (16), pp. 1217-1218.